Top Markets
Coin of the day
BCAL Diagnostics Limited BCAL Diagnostics Limited

BCAL Diagnostics Limited

BDX
Kedudukan dalam Saham #31189
BCAL Diagnostics Limited is a biotechnology firm focused on creating an... BCAL Diagnostics Limited is a biotechnology firm focused on creating an advanced, non-surgical laboratory blood test for the identification of breast cancer. Its flagship product, the BCAL test, is a lipid biomarker-based blood assay designed for potential use in breast cancer prevention strategies, early screening, and ongoing patient monitoring. This in vitro diagnostic (IVD) technology functions by detecting a unique pattern of lipid biomarkers, which are isolated from extracellular vesicles present in a patient's plasma or blood, thereby enabling the diagnosis of breast cancer cells. Established in 2010, the company's main operations are based in Sydney, Australia.
Harga Saham
$0.03808538
Modal Pasaran
$14.04M
Perubahan (1 hari)
-3.57%
Perubahan (1 tahun)
6.63%
Negara
AU
Perdagangan BCAL Diagnostics Limited (BDX)

Kategori

Nisbah P/S bagi BCAL Diagnostics Limited (BDX)
Nisbah P/S pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini BCAL Diagnostics Limited, nisbah P/S semasa (TTM) ialah 0. Pada akhir 2026, nisbah P/S syarikat ialah 0.
Sejarah nisbah P/S untuk BCAL Diagnostics Limited dari 2026 hingga 2026
Nisbah P/S pada akhir setiap tahun
Tahun Nisbah P/S Ubah
Tidak cukup data untuk tarikh yang disediakan.
Nisbah P/S untuk syarikat atau pesaing yang serupa
Syarikat Nisbah P/S Perbezaan Nisbah P/S Negara
4.72 -
US
5.67 -
US
- -
CN
16.40 -
US
9.55 -
US